Bone marrow derived endothelial progenitor cells retain their phenotype and functions after a limited number of culture passages and cryopreservation
- 116 Downloads
A critical limitation for tissue engineering and autologous therapeutic applications of bone marrow derived EPCs is their low frequency, which is even lower in number and activity level in patients with cardiovascular risk factors and other diseases. New strategies for obtaining and reserving sufficient ready-to-use EPCs for clinical use have hit major obstacles, because effects of serial passage and cryopreservation on EPC phenotype and functions are still needed to be explored. The present study aims at investigating effects of a limited number of culture passages as well as cryopreservation on EPC phenotype and functions. We isolated EPCs from rat bone marrow and cultured them up to passage 12 (totaling achievements of 40 population doublings). The phenotype and functions of fresh cultured and post-cryopreserved EPCs at passages 7 and 12, respectively, were evaluated. EPCs at passage 12 maintained the morphological characteristics, marker phenotype, Dil-ac-LDL uptake and FITC-UEA-1 binding functions, enhanced EPCs proliferation, tube formation and migration, but decreased CD133 expression compared with EPCs at passage 7. Cryopreservation caused limited impairment in EPC phenotype and functions. In brief, our results demonstrated that a limited number of culture passages and cryopreservation did not change EPC phenotype and functions, and can be used for the development of robust strategies and quality control criterion for obtaining sufficient and high-quality ready-to-use EPCs for tissue engineering and therapeutic applications.
KeywordsEndothelial progenitor cells Passage Cryopreservation Bone marrow
This work was supported by the National Natural Science Foundation of China (Nos. 31771019, 11172031, 31470901). The national key research and development plan (No. 2016YFC1101101). International Joint Research Center of Aerospace Biotechnology and 344 Medical Engineering from Ministry of Science and Technology of China, 111 Project 345 (No. B13003).
Compliance with ethical standards
Conflict of interest
The authors have no additional conflict of interest to disclose.
- Bogoslovsky T, Wang D, Maric D, Scattergood-Keepper L, Spatz M, Auh S, Hallenbeck J (2013) Cryopreservation and enumeration of human endothelial progenitor and endothelial cells for clinical trials. J Blood Disord Transfus 4:158Google Scholar
- Chen C, Zheng S, Zhang X, Dai P, Gao Y, Nan L, Zhang Y (2017) Transplantation of amniotic scaffold-seeded mesenchymal stem cells and/or endothelial progenitor cells from bone marrow to efficiently repair 3-cm circumferential urethral defect in model dogs. Tissue Eng Part A 24:47–56. https://doi.org/10.1089/ten.tea.2016.0518 CrossRefGoogle Scholar
- Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, Vigili de Kreutzenberg S (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37:2277–2282. https://doi.org/10.1161/01.str.0000236064.19293.79 CrossRefGoogle Scholar
- Garbuzova-Davis S, Haller E, Lin R, Borlongan CV (2017) Intravenously transplanted human bone marrow endothelial progenitor cells engraft within brain capillaries, preserve mitochondrial morphology, and display pinocytotic activity toward blood-brain barrier repair in ischemic stroke rats. Stem Cells 35:1246–1258. https://doi.org/10.1002/stem.2578 CrossRefGoogle Scholar
- Hristov M, Erl W, Weber PC (2003) Endothelial progenitor cells mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23:1185–1189. https://doi.org/10.1161/01.atv.0000073832.49290.b5 CrossRefGoogle Scholar
- Hur J et al (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288–293. https://doi.org/10.1161/01.atv.0000114236.77009.06 CrossRefGoogle Scholar
- Ohtani K et al (2004) Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 110:2444–2452. https://doi.org/10.1161/01.cir.0000145123.85083.66 CrossRefGoogle Scholar
- Peichev M et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors. Blood 95:952–958Google Scholar
- Sukmawati D, Tanaka R (2015) Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res 7:411–421Google Scholar
- Tepper OM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781–2786. https://doi.org/10.1161/01.cir.0000039526.42991.93 CrossRefGoogle Scholar
- Urbich C, Dimmeler S (2004) Endothelial progenitor cells characterization and role in vascular biology. Circ Res 95:343–353. https://doi.org/10.1161/01.res.0000137877.89448.78 CrossRefGoogle Scholar
- Yin Y, Liu H, Wang F, Li L, Deng M, Huang L, Zhao X (2015) Transplantation of cryopreserved human umbilical cord blood-derived endothelial progenitor cells induces recovery of carotid artery injury in nude rats. Stem Cell Res Ther 6:37. https://doi.org/10.1186/s13287-015-0022-4 CrossRefGoogle Scholar